Karuna Therapeutics, Inc.

KRTX

Sector
NA

Industry
NA

Website




Buy / Sell (dollars)

1 Month

1.2% 1.2% Complete (success)
98.8% 98.8% Complete (danger)
$430,222.50
avg. $430,222.50
$36.562M
avg. $36.562M

Buy/Sell Ratio

0.012

Transactions

22

Filers

9

3 Month

0.9% 0.9% Complete (success)
99.1% 99.1% Complete (danger)
$750,780.06
avg. $250,260.02
$85.169M
avg. $28.390M

Buy/Sell Ratio

0.009

Transactions

31

Filers

11

12 Month

5.4% 5.4% Complete (success)
94.6% 94.6% Complete (danger)
$16.482M
avg. $1.373M
$291.156M
avg. $24.263M

Buy/Sell Ratio

0.057

Transactions

56

Filers

11

24 Month

5.5% 5.5% Complete (success)
94.5% 94.5% Complete (danger)
$17.093M
avg. $712,226.46
$291.156M
avg. $12.132M

Buy/Sell Ratio

0.059

Transactions

63

Filers

14

Recent Filings - SEC Form 4


CFO Buys & Sells

The following shows events open market buys and sells made by CFOs. The CFO is likely to be the best person within a company to watch for insider signals.
On the right you can see the maximum upside and downside produced in the 7 months after the filing was made and how long it took to arrive.
These values are updated daily.

CFO data is restricted to data over 5 years old.
You need a free account to see up-to-date data.
Log in to get free access to this feature and more.

No open market CFO buys or sells found.



Filers